fda compounding glp-1 warning letters october 2025 is moving to restrict mass-marketed compounded products that aren't FDA-approved, companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA unleashes warning letters to

Regular monitoring of thyroid function GLP1 capsule users need regular thyroid function checks to detect and manage thyroid disorders early

The fungal metabolite cyclonerodiol inhibits IL-4/IL-13 induced Stat6-signaling through blocking the association of Stat6 with p38, ERK1/2 and p300

A separate study published in the International Journal of Pharmaceutics found over 7-fold greater oral bioavailability in rat models for the arginate form compared to acetate

The platform's published protocols advise patients experiencing these symptoms to stop the medication and seek emergency care immediately

They may help many patients who previously avoided injections or did not want a procedure